This page contains details of ongoing consultations where the opinion and input of BIA members is sought.
If you are commenting on any consultation as an individual or on behalf of another organisation such as RCPath and you belong to the BIA please do copy your form to BIA@Hartleytaylor.co.uk. Responders will receive a BIA Guideline Review Support Certificate which can be used to self-credit up to 10 CPD points for commenting on a consultation and we will incorporate your individual/other organisation response into the response of the BIA.
BHIVA guidelines on immunisation for adults with HIV: SARS-CoV-2 (COVID-19) 2021
SARS-CoV-2 emerged at the end of 2019 as the cause of COVID-19 resulting in a pandemic. Data from observational studies indicate that a subset of people with HIV are at increased risk of severe COVID-19 outcomes. Opportunities should not be missed to offer immunisation against SARS-CoV-2 to people with HIV. Numerous vaccine candidates are in development and several have received authorisation in the UK and worldwide, although there is limited information that is specific to people with HIV.
These guidelines aim to provide information for healthcare professionals on the use of SARS-CoV-2 immunisation in people with HIV. They are based on the interpretation of current evidence, and will be kept under review and updated as new evidence emerges.
This consultation will be open for 1 month, please provide comments to Anna.Goodman@gstt.nhs.uk by 5.00 pm on Thursday 22nd April 2021
UK SMI Q 2: Quality assurance in the diagnostic virology and serology laboratory
Public Health England (PHE) has opened a consultation in joint partnership with professional organisations.
This consultation asks for feedback in relation to the ‘UK Standards for Microbiology Investigations (UK SMI) Q 2: quality assurance in the diagnostic virology and serology laboratory’.
We have refined the process so that UK SMI users can comment more easily, if they see no requirement for amendments to the document out for consultation.
Please send comments by 12:00pm on 15 April 2021 using the consultation form provided on the website.
Enquiries may be directed to firstname.lastname@example.org
NICE medical technologies guidance – MT476 UroShield for preventing catheter-associated urinary tract infections
Further information can be found here.
Comments should be sent to Anna.Goodman@gstt.nhs.uk by 24.04.2021
Call for evidence: Long Term Condition Management of HIV
HIV Clinical Reference Group is putting together a toolkit to enable commissioners and local services to provide support to people living with HIV around long term condition management. This may relate to physical conditions that are worsened or complicated by HIV (e.g. cancer, cardiovascular and respiratory disease) or the mental health and wellbeing.
To inform this toolkit the Long Term Condition Management Working Group has commissioned a systematic review of published literature, and alongside that, we want to seek examples of best practice from those working in the field. We write to you today to invite your contributions to this evidence review: “What services, interventions and support (from the public, private or third sector) in England are available for people living with HIV to manage their overall health and wellbeing over the long-term?”
We are particularly interested in examples of services provided in rural settings, within primary and community care, involving peer support or social prescribing and from non-traditional providers such as social enterprises and charitable groups. You may be a service user, provider, commissioner or partner – we welcome submissions from all sectors.
Please click here to complete a simple form to provide contact details and information about the example you wish to highlight. If you have a “gmail” account, you can upload any files as well, or you can email them to email@example.com.
Healthcare professional survey - pharma communications strategies
Do you want to influence how you communicate with Pharma?
This survey is around pharma’s relationship with doctors and what they feel is appropriate / optimal in terms of content / channel of communication. The idea is to raise awareness in the pharmaceutical industry of how doctors want to be communicated with. The results of the survey will be published in the pharmaceutical press (pharmaphorum) as well as circulated through industry contacts. This is an opportunity for doctors to have a say in the way that they communicate with the pharma industry and should hopefully help to stimulate meaningful debate at a time where the relationship is somewhat strained.
Recently Published Consultations
NICE guideline: Cellulitis and erysipelas: antimicrobial prescribing Published Sept 2019
NICE guideline: Lyme disease Consultation closed 12/03/2019
NICE guideline: Lyme disease. Published April 2018
NICE guideline: otitis media (acute): antimicrobial prescribing. Published March 2018
NICE guidance: Cystic Fibrosis - Diagnosis and management. Published October 2017
UK SMI V 28: investigation of cytomegalovirus infection Consultation closed 27/12/2018
NICE draft guideline: Surgical site infections: prevention and treatment (update) Consultation closed 18/12/2018
NICE guideline CG191 Pneumonia in adults: diagnosis and management. Consultation closed 26/09/18
NICE draft guideline on acute cough: antimicrobial prescribing. Consultation closed 17/09/18
NICE consultation on proposed changes to the technology appraisals programme - phase 2. Consultation closed 01/03/18
UK NSC consultation on chlamydia screening in pregnancy. Consultation closed 22/02/18
BHIVA Standards of Care for People Living with HIV 2018. Consultation closed 20/02/18
BHIVA guidelines for the management of HIV infection in pregnant women 2018. Consultation closed 19/02/18
BHIVA guidelines for the management of TB/HIV co-infection in adults. Consultation closed 09/02/18
NICE guideline on hip, knee and shoulder replacement. Consultation closed 05/02/18
UK SMI B 29: Investigation of specimens for screening for MRSA. Consultation closed 02/02/18
Use of organs from Hepatitis C viraemic donors in Hepatitis C negative recipients. Consultation closed 02/02/18
NICE QS on cystic fibrosis. Consultation closed 19 January 2018. Expected publication: 18 May 2018
Topic engagement exercise: NICE emergency and acute medical care QS. Consultation closed 01/12/17. Click for BIA comments.
UK NSC consultation: guidance on the development, production and review of information to support screening. Consultation closed 16/11/17. We hope to publish responses and an updated version of the guidance within 12 weeks of the conclusion of the consultation.
NICE QS Consultation: HIV testing - encouraging uptake. Published September 2017.
NICE QS Consultation: Physical health of people in prison. Published September 2017.
UK NSC consultation: antenatal screening for human t-cell lymphotrophic virus (HTLV). Review completed Dec 2017
PHE UK guidelines for the management of contacts of invasive Group A Streptococcus infection in community settings. Consultation closed 02/10/17
British Society for Rheumatology draft guidelines: Biological DMARD safety guidelines in inflammatory arthritis. Consultation closed 04/09/17.
NICE guidance on emergency and acute medical care in over 16s: service delivery and organisation. Consultation closed 14/08/17. Expected publication date: 20/12/17. Click for BIA comments submitted
NICE guideline on sore throat (acute): antimicrobial prescribing. Consultation closed 14/08/17. Expected publication date tbc. Click for BIA comments submitted
Stakeholder consultation: High Consequence Infectious Diseases Interim Paediatric. Consultation closed 19/07/17.
NICE draft guideline: Flu vaccination - increasing uptake. Expected publication date: 10/01/2018.
Click for BIA comments on this consultation
NICE Surveillance Reports - Healthcare associated infections: prevention and control in primary and community care. Survey closed 27/06/17.
UK SMI V 04 - Investigation of hepatitis B infection. Published June 2017
NICE draft guideline on sinusitis (acute): antimicrobial prescribing. Published October 2017
NICE draft guideline on cystic fibrosis: diagnosis and management. Published 25 October 2017. Click for BIA comments.
UK National Screening Committee consultation: screening for Group B Streptococcus in pregnancy. Review completed March 2017
NICE Quality Standard Topic Engagement Exercise: HIV testing: encouraging uptake. Published Sept 2017
NICE guideline on Managing Common Infections. Consultation closed 28/11/16. Expected publication date tbc.
NICE Quality Standard Consultation: Vaccine uptake in under 19's. Published March 2017
NICE Diagnostics Consultation Document: Integrated multiplex PCR tests for identifying gastrointestinal pathogens in people with suspected gastroenteritis (xTAG Gastrointestinal Pathogen Panel, FilmArray GI Panel and Faecal Pathogens B assay). Published Jan 2017
NICE Consultation on Abbreviated Technology Appraisal (ATA) Process. Consultation closed 24/08/16. Comments are currently being reviewed and an updated version is due to be presented to the NICE board in November 2016.
NICE Guideline: Sickle cell disease: managing acute painful episodes in hospital - Surveillance consultation. Consultation closed 02/06/16. Anticipated review decision publication: August 2016
UK SMI V 37: Chlamydia trachomatis infection - testing by Nucleic Acid Amplification Tests (NAAT). Published May 2018, updated Jan 2017
NICE draft guideline consultation: Multimorbidity: clinical assessment and management. Guideline published September 2016.